NASDAQ$BRKR
Bruker Corp · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Bruker's Q3 2023 financial results were announced, demonstrating strong revenue growth and increased EPS.
Bruker reported Q3 2023 revenues of $742.8 million, a 16.3% increase year-over-year, with organic revenue up 10.9%. GAAP EPS was $0.60, and non-GAAP EPS was $0.74, up 12.1% year-over-year. The company increased its FY 2023 revenue guidance to $2.88-$2.91 billion, implying a reported revenue growth of 14%-15% year-over-year.
- Q3 2023 revenues reached $742.8 million, reflecting a 16.3% year-over-year increase and 10.9% organic growth.
- GAAP EPS for Q3 2023 was reported at $0.60, while non-GAAP EPS rose to $0.74, marking a 12.1% year-over-year increase.
- The company has raised its full-year 2023 revenue guidance to between $2.88 billion and $2.91 billion.
- Bruker's acquisition of the Cellular Analysis business (formerly PhenomeX) was completed in early October.
Headline financials
Revenue & EPS history
Bruker · Revenue · Quarterly
$743M
Revenue by segment
Bruker · $70.6M total across 1 segment · Q3 2023
- BEST$70.6M+19.1%100.0%
Forward guidance
Bruker is increasing its revenue guidance for FY 2023 to a range of $2.88-$2.91 billion. Non-GAAP EPS is expected to be $2.48-$2.53, with organic revenue growth of 11.5%-12.5%.
Tailwinds
- Revenue guidance increased to $2.88-$2.91 billion.
- Organic revenue growth expected to be 11.5%-12.5%.
- M&A revenue growth contribution of approximately 2.5%.
- Constant currency revenue growth of 14%-15%.
- Non-GAAP EPS expected to be $2.48-$2.53.
Headwinds
- Cellular Analysis business expected to have a negative impact of ~$0.12 on non-GAAP EPS in Q4 2023.
- Overall, a $0.07 decrease from prior FY 2023 guidance due to Cellular Analysis business.
- Cellular Analysis is expected to be slightly dilutive in FY 2024.
- Updated non-GAAP EPS guidance reflects a $0.05 expected increase from the core business.
- Bruker is rapidly right-sizing the Cellular Analysis cost structure
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+0.8%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+3.3%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+14.1%
Q1 2019
Best reaction
-13.1%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.2% | +13.8% | +48.3% | |
| Q4 2025 | -11.6% | -10.2% | -20.5% | |
| Q3 2025 | +6.4% | +2.5% | +22.9% | |
| Q1 2025 | +3.4% | +2.1% | -2.9% | |
| Q4 2024 | -1.0% | -1.7% | -11.0% | |
| Q3 2024 | -0.6% | -2.7% | -1.5% | |
| Q2 2024 | -5.1% | -2.4% | +2.8% | |
| Q1 2024 | -11.4% | -5.9% | -17.1% | |
| Q4 2023 | +13.4% | +15.9% | +30.1% | |
| Q3 2023 | +3.2% | +2.2% | +15.9% | |
| Q2 2023 | -6.7% | -7.6% | -7.1% | |
| Q1 2023 | -2.1% | -4.9% | -11.0% | |
| Q4 2022 | +5.2% | +7.3% | +1.0% | |
| Q3 2022 | +9.5% | +8.7% | +9.6% | |
| Q2 2022 | -7.4% | -9.3% | -18.2% | |
| Q1 2022 | +1.2% | -4.0% | +5.3% | |
| Q4 2021 | -7.7% | -3.9% | -12.1% | |
| Q3 2021 | +1.7% | +1.7% | +0.9% | |
| Q2 2021 | -1.8% | +0.4% | +8.7% | |
| Q1 2021 | -0.5% | -0.0% | +1.4% | |
| Q4 2020 | +1.1% | +3.5% | -1.1% | |
| Q3 2020 | +3.4% | +9.2% | +21.6% | |
| Q2 2020 | +0.2% | -1.1% | -4.1% | |
| Q1 2020 | +6.2% | +4.3% | +16.9% | |
| Q4 2019 | -4.0% | -21.4% | -8.1% | |
| Q3 2019 | +12.4% | +6.8% | +14.9% | |
| Q2 2019 | -13.1% | -12.7% | -9.8% | |
| Q1 2019 | +14.1% | +11.3% | +9.6% | |
| Q4 2018 | +6.3% | +7.4% | +8.5% | |
| Q3 2018 | +6.6% | +6.9% | +5.8% | |
| Q2 2018 | +7.4% | +7.0% | +9.1% | |
| Q1 2018 | +2.0% | +2.9% | +3.4% | |
| Q4 2017 | -7.8% | -5.9% | -6.8% | |
| Q3 2017 | +4.5% | +2.8% | +9.2% | |
| Q2 2017 | -1.2% | -3.1% | +3.2% | |
| Q1 2017 | +3.8% | +4.7% | +12.1% | |
| Q4 2016 | -1.8% | -1.2% | -3.1% | |
| Q3 2016 | +3.6% | +8.9% | +10.1% | |
| Q2 2016 | -12.2% | -10.6% | -9.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +9.5% | — | — | |
| Q3 2015 | +7.8% | — | — | |
| Q2 2015 | -5.4% | — | — | |
| Q1 2015 | +10.6% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | -12.5% | — | — | |
| Q2 2014 | -9.4% | — | — | |
| Q1 2014 | -0.8% | — | — | |
| Q4 2013 | +2.0% | — | — | |
| Q3 2013 | -7.1% | — | — | |
| Q2 2013 | +11.1% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q4 2012 | +8.3% | — | — | |
| Q3 2012 | +4.1% | — | — | |
| Q2 2012 | -1.6% | — | — | |
| Q1 2012 | +7.4% | — | — | |
| Q4 2011 | -0.9% | — | — | |
| Q4 2009 | -0.9% | — | — | |
| Q3 2010 | -4.0% | — | — | |
| Q3 2011 | -4.0% | — | — | |
| Q2 2010 | +4.0% | — | — | |
| Q2 2011 | +4.0% | — | — | |
| Q1 2010 | +1.9% | — | — | |
| Q4 2010 | +1.9% | — | — | |
| Q1 2011 | +1.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro